Skip to main content
Livermore
Livermore
ZHEN

Virtus ETF Advisers LLC

SEC CIK
0001587281
Latest filing
Aug 11, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Virtus ETF Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
9,249
Value
$753.9K
% of portfolio
0.3%
Quarters held
21
Since Q1 2021
Holdings of ARWR by Virtus ETF Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,249$753.9K0.3%+444+5.0%AddedHolders
Q1 20268,805$552.1K0.3%−5,657−39.1%ReducedHolders
Q4 202514,462$960.1K0.5%00.0%UnchangedHolders
Q3 202514,462$498.8K0.3%−1,182−7.6%ReducedHolders
Q2 202515,644$247.2K0.2%+15,644NewHolders
Q1 20250$00.0%−3,211−100.0%Sold outHolders
Q4 20243,211$60.4K<0.1%−267−7.7%ReducedHolders
Q3 20243,478$67.4K<0.1%+62+1.8%AddedHolders
Q2 20243,416$88.8K<0.1%+385+12.7%AddedHolders
Q1 20243,031$86.7K<0.1%−212−6.5%ReducedHolders
Q4 20233,243$99.2K0.1%+444+15.9%AddedHolders
Q3 20232,799$75.2K<0.1%−278−9.0%ReducedHolders
Q2 20233,077$109.7K0.1%−10.0%ReducedHolders
Q1 20233,078$78.2K<0.1%−1,186−27.8%ReducedHolders
Q4 20224,264$172.9K0.1%+522+13.9%AddedHolders
Q3 20223,742$124.0K<0.1%+24+0.6%AddedHolders
Q2 20223,718$131.0K<0.1%+1,460+64.7%AddedHolders
Q1 20222,258$104.0K<0.1%−142−5.9%ReducedHolders
Q4 20212,400$159.0K0.1%−3−0.1%ReducedHolders
Q3 20212,403$150.0K0.1%−127−5.0%ReducedHolders
Q2 20212,530$210.0K0.1%−1,476−36.8%ReducedHolders
Q1 20214,006$266.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.